UBS Group AG
NYSE:UBSBanks - Diversified
+$1.10 today
- Market cap
- $139.77B
- Beta
- 0.84
- P/E (TTM)
- 20.2
- EPS (TTM)
- $2.52
- Dividend yield
- 2.12%
Volume 1.72M
Average 2.52M
UBS Short-term Investments
Marketable securities and deposits the company expects to convert to cash within a year.
UBS Group AGNYSE: UBS
Short-term Investments · Q2 FY2026 · quarter ended Jun 2026
Short-term investments rises 2089.0% from a year ago
Short-term investments stood at $150.43B at the end of Q2 FY2026, up 2089.0% from a year earlier and up 11.3% from the prior quarter. Over 3 fiscal years it compounded at +38.1% a year.
Context
- Short-term investments amounted to 8.8% of total assets at the end of Q2 FY2026, up 8.4 pp from a year earlier.
- Short-term investments increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether short-term investments keeps rising in the next quarterly balance sheet after a +2089.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Short-term Investments history
USD · from the balance sheet
- Latest · FY2025
- 188.57B USD
- Year-over-year change
- +8490.8%
- 4-year CAGR
- +8.7%
| Period | Period end | Short-term Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 188.57B | +8490.8% |
| FY2024 | 2024-12-31 | 2.2B | -97.7% |
| FY2023 | 2023-12-31 | 97.15B | +35.8% |
| FY2022 | 2022-12-31 | 71.56B | -47.0% |
| FY2021 | 2021-12-31 | 135.12B | — |
Short-term Investments vs competitors
How UBS compares with its peers on the latest reported figures
- Peers report in different currencies, so short-term investments is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +2089.0% is the highest of 10, against a peer median of +99.1%.
- Short-term investments amounts to 8.8% of total assets for UBS, versus a peer median of 9.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $2.38T USD | +99.1% | +26.8% | 46.7% | |
| Sep 2026 | $1.11T USD | +241.4% | +10.9% | 37.7% | |
| Sep 2026 | $832B USD | +139.8% | -1.4% | 38.1% | |
| Jun 2026 | $404.97B USD | +28.7% | — | 11.8% | |
| Jul 2026 | CA$320.47B CAD | +161.1% | +52.1% | 15.2% | |
| Jun 2026 | $150.43B USD | +2089.0% | +38.1% | 8.8% | |
| Sep 2026 | $120.1B USD | +306.1% | +4.5% | 7.1% | |
| Sep 2026 | $0 USD | -100.0% | +49.1% | 0.0% | |
| Jul 2026 | CA$0 CAD | -100.0% | +9.0% | 0.0% | |
| Sep 2026 | ¥0 JPY | — | — | 0.0% | |
| Jun 2026 | €0 EUR | -100.0% | +22.8% | 0.0% | |
| Peer median (excluding UBS) | — | +99.1% | +16.9% | 9.4% | |
Competitors are the stored peer set for UBS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 194.8B | 172.83B | 317.21B | 225.71B | 209.86B |
| Short-term Investments | 135.12B | 71.56B | 97.15B | 2.2B | 188.57B |
| Net Receivables | 26.33B | 23.43B | 35.89B | 38.87B | 35.58B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | (1.73B) |
| Total Current Assets | 357.35B | 268.89B | 452.33B | 268.45B | 434B |
| Property, Plant & Equipment (Net) | 12.89B | 12.29B | 17.85B | 15.5B | 16.06B |
| Goodwill | 6.13B | 6.04B | 6.04B | 5.99B | 4.81B |
| Intangible Assets | 252M | 224M | 1.47B | 897M | 698.31M |
| Long-term Investments | 672.56B | 717.02B | 1.1T | 897.52B | 1T |
| Tax Assets | 8.88B | 9.39B | 10.68B | 11.13B | 11.53B |
| Other Non-current Assets | 59.12B | 90.52B | 126.3B | 365.53B | 147.26B |
| Total Non-current Assets | 759.83B | 835.48B | 1.26T | 1.3T | 1.18T |
| Total Assets | 1.12T | 1.1T | 1.72T | 1.57T | 1.62T |
| Account Payables | 45.14B | 47.03B | 49.21B | 54.9B | 62.2B |
| Short-term Debt | 55.01B | 49.21B | 60.34B | 51.14B | 53.94B |
| Tax Payables | 1.99B | 1.66B | 2.58B | 2.83B | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 587.96B | 567.62B | 901.02B | 809.85B | 872.83B |
| Total Current Liabilities | 689.99B | 665.62B | 1.01T | 919.03B | 1.02T |
| Long-term Debt | 172.09B | 160.27B | 333.65B | 297.32B | 297.92B |
| Deferred Tax Liabilities | 300M | 236M | 325M | 340M | 471M |
| Deferred Revenue (Non-current) | 240M | 235M | 635M | 555M | 683M |
| Other Non-current Liabilities | 190.01B | 217.45B | 276.65B | 257.62B | 194.46B |
| Total Non-current Liabilities | 366.19B | 381.52B | 616.77B | 560.43B | 497.79B |
| Total Liabilities | 1.06T | 1.05T | 1.63T | 1.48T | 1.53T |
| Common Stock | 322M | 304M | 346M | 346M | 334M |
| Retained Earnings | 43.85B | 50B | 74.88B | 78.04B | 82.74B |
| Accumulated OCI | 5.24B | (103M) | 2.46B | 1.09B | 5.81B |
| Other Stockholders Equity | 0 | (1M) | 0 | 0 | 0 |
| Minority Interest | 340M | 342M | 531M | 494M | 271M |
| Total Equity | 61B | 57.22B | 86.64B | 85.57B | 90.48B |
| Total Debt | 230.65B | 212.81B | 399.5B | 353.05B | 356.12B |
| Net Debt | 35.86B | 39.99B | 82.28B | 127.35B | 146.26B |
UBS Group AG
NYSE:UBS
Intrinsic Alpha fair value
Locked
Current Price
$45.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.